Peter W. Park

891 total citations
17 papers, 605 citations indexed

About

Peter W. Park is a scholar working on Pharmacology, Physiology and Molecular Biology. According to data from OpenAlex, Peter W. Park has authored 17 papers receiving a total of 605 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmacology, 9 papers in Physiology and 4 papers in Molecular Biology. Recurrent topics in Peter W. Park's work include Smoking Behavior and Cessation (6 papers), Musculoskeletal pain and rehabilitation (5 papers) and Nicotinic Acetylcholine Receptors Study (4 papers). Peter W. Park is often cited by papers focused on Smoking Behavior and Cessation (6 papers), Musculoskeletal pain and rehabilitation (5 papers) and Nicotinic Acetylcholine Receptors Study (4 papers). Peter W. Park collaborates with scholars based in United States, United Kingdom and Philippines. Peter W. Park's co-authors include Raymond C. Rosen, Vera J. Stecher, Irwin Goldstein, Arthur L. Burnett, Ching‐Ray Yu, Robert West, Jon O. Ebbert, John R. Hughes, Thomas McRae and Cristina Russ and has published in prestigious journals such as JAMA, PLoS ONE and Neuropsychopharmacology.

In The Last Decade

Peter W. Park

17 papers receiving 580 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter W. Park United States 11 276 155 154 83 72 17 605
R. K. S. Lim United States 13 326 1.2× 129 0.8× 102 0.7× 49 0.6× 79 1.1× 19 890
Francesca Nicosia United States 16 284 1.0× 130 0.8× 141 0.9× 82 1.0× 14 0.2× 46 824
Naji Alamuddin United States 20 262 0.9× 241 1.6× 119 0.8× 233 2.8× 16 0.2× 45 1.1k
Richa Sood United States 19 139 0.5× 42 0.3× 57 0.4× 134 1.6× 27 0.4× 40 934
Yung‐Chieh Yen Taiwan 15 108 0.4× 68 0.4× 41 0.3× 86 1.0× 24 0.3× 41 875
Til Stürmer United States 13 90 0.3× 111 0.7× 68 0.4× 66 0.8× 11 0.2× 15 591
Wai Tak Hung Australia 15 125 0.5× 38 0.2× 56 0.4× 52 0.6× 34 0.5× 24 671
Andrew D. Mosholder United States 15 157 0.6× 69 0.4× 61 0.4× 46 0.6× 14 0.2× 38 743
Brent Caldwell New Zealand 10 359 1.3× 199 1.3× 70 0.5× 61 0.7× 22 0.3× 12 741
Jonathan G. Levine United States 7 76 0.3× 145 0.9× 34 0.2× 55 0.7× 43 0.6× 8 615

Countries citing papers authored by Peter W. Park

Since Specialization
Citations

This map shows the geographic impact of Peter W. Park's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter W. Park with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter W. Park more than expected).

Fields of papers citing papers by Peter W. Park

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter W. Park. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter W. Park. The network helps show where Peter W. Park may publish in the future.

Co-authorship network of co-authors of Peter W. Park

This figure shows the co-authorship network connecting the top 25 collaborators of Peter W. Park. A scholar is included among the top collaborators of Peter W. Park based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter W. Park. Peter W. Park is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Andersen, Kathleen M., Farid Khan, Peter W. Park, et al.. (2024). Using a data-driven approach to define post-COVID conditions in US electronic health record data. PLoS ONE. 19(4). e0300570–e0300570. 1 indexed citations
2.
Margolis, Jay, Nicole Princic, David M. Smith, et al.. (2019). Economic Impact of Adherence to Pain Treatment Guidelines in Chronic Pain Patients. Pain Medicine. 20(10). 1907–1918. 10 indexed citations
3.
Cicero, Theodore J., Richard C. Dart, Jack Mardekian, et al.. (2019). Real-world misuse, abuse, and dependence of abuse-deterrent versus non-abuse-deterrent extended-release morphine in Medicaid non-cancer patients. Postgraduate Medicine. 131(3). 225–229. 4 indexed citations
4.
Goldstein, Irwin, Arthur L. Burnett, Raymond C. Rosen, Peter W. Park, & Vera J. Stecher. (2018). The Serendipitous Story of Sildenafil: An Unexpected Oral Therapy for Erectile Dysfunction. Sexual Medicine Reviews. 7(1). 115–128. 109 indexed citations
5.
Lee, Lauren J., Qian Li, Marianna Bruno, et al.. (2018). Healthcare Costs of Smokers Using Varenicline Versus Nicotine-Replacement Therapy Patch in the United States: Evidence from Real-World Practice. Advances in Therapy. 36(2). 365–380. 6 indexed citations
6.
Nakamura, Masakazu, et al.. (2017). Efficacy of Varenicline for Cigarette Reduction Before Quitting in Japanese Smokers: A Subpopulation Analysis of the Reduce to Quit Trial. Clinical Therapeutics. 39(4). 863–872. 7 indexed citations
7.
Arnold, Lesley M., Bill McCarberg, Andrew Clair, et al.. (2017). Dose–response of pregabalin for diabetic peripheral neuropathy, postherpetic neuralgia, and fibromyalgia. Postgraduate Medicine. 129(8). 921–933. 17 indexed citations
8.
Walker, Chris, Margaret Noyes Essex, Chunming Li, & Peter W. Park. (2016). Celecoxib versus diclofenac for the treatment of ankylosing spondylitis: 12-week randomized study in Norwegian patients. Journal of International Medical Research. 44(3). 483–495. 17 indexed citations
9.
Stanos, Steven P., Marina Brodsky, Charles E. Argoff, et al.. (2016). Rethinking chronic pain in a primary care setting. Postgraduate Medicine. 128(5). 502–515. 66 indexed citations
10.
Park, Peter W., et al.. (2015). Cost Burden of Chronic Pain Patients in a Large Integrated Delivery System in the United States. Pain Practice. 16(8). 1001–1011. 47 indexed citations
11.
Lamerato, Lois, et al.. (2015). Prevalence of Chronic Pain in a Large Integrated Healthcare Delivery System in the U.S.A. Pain Practice. 16(7). 890–898. 15 indexed citations
12.
Ebbert, Jon O., John R. Hughes, Robert West, et al.. (2015). Effect of Varenicline on Smoking Cessation Through Smoking Reduction. JAMA. 313(7). 687–687. 142 indexed citations
13.
Coyne, Karin S., Mary Kay Margolis, Joseph C. Cappelleri, et al.. (2013). Prevalence of gastroprotective agent (GPA) use in adults with arthritis in the United States. Current Medical Research and Opinion. 29(5). 421–433. 5 indexed citations
14.
Essex, Margaret Noyes, et al.. (2013). Safety of celecoxib compared with placebo and non-selective NSAIDs: cumulative meta-analysis of 89 randomized controlled trials. Expert Opinion on Drug Safety. 12(4). 465–477. 32 indexed citations
15.
Park, Peter W., et al.. (2011). Observational study of safety and efficacy of varenicline for smoking cessation among Filipino smokers. Current Medical Research and Opinion. 27(10). 1869–1875. 4 indexed citations
16.
Bolliger, Chris T., et al.. (2011). Effects of Varenicline in Adult Smokers: A Multinational, 24-Week, Randomized, Double-Blind, Placebo-Controlled Study. Clinical Therapeutics. 33(4). 465–477. 44 indexed citations
17.
King, David P., Sara A. Paciga, Eve H. Pickering, et al.. (2011). Smoking Cessation Pharmacogenetics: Analysis of Varenicline and Bupropion in Placebo-Controlled Clinical Trials. Neuropsychopharmacology. 37(3). 641–650. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R. K. S. Lim Breakdown of academic impact, for papers by Francesca Nicosia Breakdown of academic impact, for papers by Naji Alamuddin Breakdown of academic impact, for papers by Richa Sood Breakdown of academic impact, for papers by Yung‐Chieh Yen Breakdown of academic impact, for papers by Til Stürmer Breakdown of academic impact, for papers by Wai Tak Hung Breakdown of academic impact, for papers by Andrew D. Mosholder Breakdown of academic impact, for papers by Brent Caldwell Breakdown of academic impact, for papers by Jonathan G. Levine
Rankless by CCL
2026